Long awaited news finally arrives. One of the most important markers of how a fertility program performs their job is pregnancy rates, right? More important to look at though, is live birth rates.
As patients, we don’t necessarily care about the results of certain tests. We don’t care if the cycle is perfect. If our eggs are spectacular if the semen analysis shows dramatic improvement. Those things are great, but they are not really the point. Believe it or not? We don’t even care if we become pregnant.
The gold, no, platinum standard? Baby in our arms. That’s what live birth rate means. That’s what we want. We want our babies.
Reproductive Medicine Associates of Connecticut (RMACT) is a special place. It’s a group of men and women who care about their jobs; helping you grow your families. We do that in so many ways, starting with excellent medical and scientific care.
We are lucky to work in a field, reproductive health, where we can have those skills verified. Where our excellence is quantifiable.
RMACT is not just their pregnancy rates. Read below what Dr’s Leondires, Richlin and Hurwitz have to say about the practice that they have held in their loving and capable hands and grown to the extraordinary place that it is.
Pregnancy Success Rates vs. Live Birth Rates
We patients come here to become pregnant. So yes, those pregnancy rates matter. Of course they do. (Please know as well that RMACT treats patients with a wide variety of diagnoses, we do not pick only patients with a good chance of success.) So it is about celebrating these wonderful live birth rates. It’s wonderful, affirming news for our practice, our patients and our patients to be.
RMACT is very proud of the hard work, compassion and skills that it has taken from the entire team to be able to have these live birth rate numbers.
Because they’re not just live birth rate numbers.
And that’s the whole point, isn’t it.~Lisa Rosenthal
PS - We were excited to share this news and so have not yet updated our website. Our rates will be updated on rmact.com by Thursday, March 12th, 2015.
Reproductive Medicine Associates of Connecticut Has Live Birth Rate 22% Higher Than the National Fertility Practices’ Average, According to SART
Connecticut Infertility Patients Have Access to the Latest Advances in IVF and Reproductive Care
NORWALK, CT (March 10, 2015) – The Society for Assisted Reproductive Technologies (SART), an independent non-profit organization responsible for gathering, verifying and distributing data from fertility practices nationwide, released its latest report for all U.S.-based in vitro fertilization (IVF) programs. Based on the greatly anticipated SART clinic summary report, Reproductive Medicine Associates of Connecticut (RMACT) continues to be a leader in the fertility field with a live birth rate significantly higher for women under 35 with thawed, non-donor cycles; RMACT has a live birth rate of 66% (84/127) as compared to 44% nationally.
“We offer infertility patients from across Connecticut and New York something different here at RMACT and our latest IVF delivery rates illustrate those differences,” said Dr. Mark Leondires, medical director for RMACT. “Extended embryo culture, endometrial synchrony, Select CCS (comprehensive chromosome screening), as well as yoga and acupuncture are all components of our success. Our goal is not simply to achieve pregnancies, it’s to achieve healthy pregnancies, one baby at a time.”
Having the most state-of-the-art IVF lab in Connecticut and the region also positively affects treatment decisions. “By having an exceptional IVF lab, we have the ability and confidence to transfer fewer embryos per cycle. By transferring fewer embryos, we’re preventing complicated multiple pregnancies, yet we’re still able to maintain some of the highest delivery rates in the country,” said Dr. Spencer Richlin, surgical director for RMACT.
Dr. Joshua M. Hurwitz, a fertility specialist with RMACT, added: “There is a sea-change in IVF going on right now. Previously, we believed that a fresh embryo transfer gave us the best chance for pregnancy, but now we are seeing success rates from our frozen embryo cycles jump ahead. This is due to a major advance in embryo cryopreservation techniques, termed vitrification, as well our ability to screen each embryo to make sure it is chromosomally normal, termed Select CCS. Frozen embryo transfer cycles are the future of fertility treatment; they give us the best chance for implantation, healthier pregnancies and the ability to achieve the ultimate goal of highest pregnancy rates one baby at a time.”
The entire RMACT fertility team contributes to the overall success of each patient, and includes five board-certified reproductive endocrinologists, nurses, therapists, a nutritionist, acupuncturists, financial advisors and the third party reproduction team. RMACT’s robust medical team gives the physicians an opportunity to consult and collaborate with each other and benefit from their broad medical expertise. Patients are also counseled in an integrative manner and encouraged to improve their overall health, including nutrition and stress management, through RMACT’s Integrated Fertility & Wellness Program.
About Reproductive Medicine Associates of Connecticut (RMACT)
RMACT specializes in the treatment of infertility, including assisted reproductive technologies (ART) such as intrauterine insemination (IUI), in-vitro fertilization (IVF), and Comprehensive Chromosome Screening (Select CCS). RMACT, Fairfield County’s largest fertility clinic and egg donation center, is one of 11 leading In Vitro Fertilization (IVF) centers nationwide chosen by In Vitro Sciences to participate in its Centers of Excellence program. RMACT has offices in Norwalk, Danbury, Stamford and Trumbull, and an affiliate New York fertility clinic serving Putnam and Dutchess counties. RMACT also offers infertility treatment financing and support services, such as nutrition counseling, psychological counseling, acupuncture and yoga, through RMACT’s Integrated Fertility and Wellness Center.
The RMACT team includes lead physicians Drs. Mark P. Leondires, Spencer S. Richlin and Joshua M. Hurwitz, as well as fertility specialists Drs. Cynthia M. Murdock, and Shaun C. Williams. All five physicians are Board-Certified Reproductive Endocrinologists and are members of the American Society for Reproductive Medicine (ASRM) and the Society for Assisted Reproductive Technology (SART). Each has received numerous awards, and all five are Castle Connolly "Top Doctors." RMACT’s IVF laboratory is accredited by the College of American Pathologists (CAP), and CLIA; other accreditations include the Accreditation Association for Ambulatory Health Care (AAAHC) and the American Institute for Ultrasound in Medicine (AIUM). For more information visit http://www.RMACT.com or find us on Facebook.
The Society for Reproductive Technologies (SART) is the primary organization of professionals dedicated to the practice of IVF, or assisted reproductive technologies (ART). The mission of SART is to establish and maintain standards for ART in an effort to better serve its members and patients. The organization represents the majority of the ART clinics in the United States at around 90% clinic participation. One of SART’s most important functions is to collect birth outcome data from its member clinics. The clinic summary data helps patients view data on a national and individual basis. Patients may also contact infertility clinics through SART.
Please note a comparison of clinic success rates may not be meaningful because a patient’s medical characteristics, treatment approaches and entrance criteria for ART may vary from clinic to clinic.
 RMACT’s live birth rate is 66% (84/127) as compared to 44% nationally, as reported to SART. A patient comparison of clinic success rates may not be meaningful because patient medical characteristics, treatment approaches and entrance criteria for ART may vary from clinic to clinic.